-
Aug 31, 2024 | 
espanol.medscape.com | Susan Hughes
LONDRES.
-
Jul 30, 2024 | 
mdedge.com | Susan Hughes
Publish date: July 30, 2024 Fecal microbiota transplantation (FMT) for Parkinson’s disease is safe but does not offer clinically meaningful improvement in symptoms, results of a new, randomized placebo-controlled trial show. However, investigators discovered some interesting insights from the study, which they believe may help in designing future “improved, and hopefully successful, trials” with the intervention.
-
Jul 24, 2024 | 
espanol.medscape.com | Susan Hughes
La relación entre la influenza y un aumento del riesgo de infarto agudo de miocardio a corto plazo se ha reafirmado en un nuevo estudio, que muestra que el riesgo parece ser especialmente elevado en individuos sin diagnóstico previo de arteriopatía coronaria.[1] "Los resultados de nuestro estudio confirman los hallazgos anteriores de un mayor riesgo de infarto de miocardio durante o inmediatamente después de una infección aguda a grave por el virus de influenza, y plantean la idea de...
-
Jul 18, 2024 | 
mdedge.com | Susan Hughes
Publish date: July 18, 2024 The link between influenza infection and a rise in short-term risk for acute myocardial infarction (MI) has been reaffirmed in a new study, which showed the risk appears to be particularly elevated in individuals with no prior diagnosis of coronary artery disease.
-
Jun 14, 2024 | 
univadis.es | Susan Hughes
Nuevos hallazgos desafían la práctica de reducir rápidamente la presión arterial en el ictus isquémico agudo para permitir una trombólisis rápida.[1] El estudio observacional grupal mostró que las y los pacientes tratados en hospitales que siguieron la práctica recomendada por las guías de reducir rápidamente la presión arterial no obtuvieron mejores resultados (y de hecho mostraron una tendencia hacia peores resultados) que aquellos tratados en hospitales que no redujeron la presión...
-
Jun 4, 2024 | 
mdedge.com | Susan Hughes
Publish date: June 4, 2024 — The anti-inflammatory agent colchicine failed to show significant benefit in the treatment of patients with non-cardioembolic ischemic stroke in the primary analysis of the CONVINCE trial. However, the results did reveal a significant reduction in recurrent stroke and cardiovascular events in the per-protocol analysis and in the subgroup of patients with coronary artery disease.
-
Jun 4, 2024 | 
espanol.medscape.com | Susan Hughes
Nuevos hallazgos desafían la práctica de reducir rápidamente la presión arterial en el ictus isquémico agudo para permitir una trombólisis rápida.[1] El estudio observacional grupal mostró que las y los pacientes tratados en hospitales que siguieron la práctica recomendada por las guías de reducir rápidamente la presión arterial no obtuvieron mejores resultados (y de hecho mostraron una tendencia hacia peores resultados) que aquellos tratados en hospitales que no redujeron la presión...
-
May 23, 2024 | 
mdedge.com | Susan Hughes |Unclear Mechanisms
BASEL, SWITZERLAND — New findings challenge the practice of rapidly lowering blood pressure (BP) in acute ischemic stroke to allow for speedy thrombolysis. The observational cluster study showed that patients treated in hospitals that followed the guideline-recommended practice of rapidly reducing BP did no better — and actually showed a trend toward worse outcomes — than those treated in hospitals that did not lower BP, even though this meant fewer patient received thrombolysis.
-
Feb 7, 2024 | 
medscape.com | Susan Hughes
A combination of biologically active components of Ginkgo biloba given by intravenous (IV) injection for 14 days was associated with improved early cognitive recovery in patients with acute ischemic stroke, in a placebo-controlled trial. These results will be presented at the International Stroke Conference 2024 being held this week in Phoenix, Arizona. The study included 3452 patients from 100 Chinese centers with acute ischemic stroke enrolled within 48 hours of onset.
